NYXH Stock Analysis: Buy, Sell, or Hold?
NYXH - Nyxoah SA Ordinary Shares
$1.45
-1.43 (-49.65%)
▼
5d:
-51.34%
30d:
-54.97%
90d:
-61.23%
WAIT
LOW Confidence
Analysis Updated: Jun 5, 2026 12:00 AM ET
Earnings: May 19, 2026
0d
Get Alerted When NYXH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NYXH is down 51.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NYXH is down 51.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: NYXH is currently trading at $1.45, which is considered oversold relative to its 30-day fair value range of $2.62 to $3.24.
Technical Outlook: Technically, NYXH is in a strong downtrend. The price is currently testing key support at $2.68. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 49.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.97 (+518.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NYXH is in a strong downtrend. The price is currently testing key support at $2.68. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 49.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.97 (+518.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.62 -
$3.24
Company Quality Score
54/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-49.7%)
- BULLISH: Trading 518.4% below Wall St target ($8.97)
- WARNING: Recommendation downgraded due to -51.3% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$2.62 -
$3.24
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.68
Resistance Level
$3.06
Current Trend
Strong Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.26
Wall Street Target
$8.97
(+518.4%)
Revenue Growth (YoY)
498.9%
Share & Embed Analysis
Last updated: June 06, 2026 7:54 AM ET
Data refreshes hourly during market hours. Next update: 8:54 AM
Data refreshes hourly during market hours. Next update: 8:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NYXH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 63 BUY |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$573 | 56 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$179 | 54 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$91 | 64 BUY |
|
AVTR
Avantor Inc |
HOLD
21 analysts |
$10 | 64 BUY |
